APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Pain Management Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Pain Management Drug Industry Growth and Trends Forecast to 2032

22 December 2025120 pages

Choose your research edition.

Industry ResearchHuman Pain Management Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Pain Management Drug Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Human Pain Management Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Pain Management Drug Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Pain Management Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

According to APO Research, the global Human Pain Management Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Pain Management Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Pain Management Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Pain Management Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Human Pain Management Drug market include Teva Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Novartis AG, Pfizer Inc., GSK plc., Bayer AG and Bristol Myers Squibb Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Pain Management Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Pain Management Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Pain Management Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Pain Management Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Human Pain Management Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Pain Management Drug Market by Company

Teva Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Sanofi S.A.

Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

Novartis AG

Pfizer Inc.

GSK plc.

Bayer AG

Bristol Myers Squibb Co.

AbbVie Inc. (Allergan plc)

AstraZeneca

Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

Viatris

Purdue Pharmaceuticals L.P.

Procter & Gamble

Perrigo Company Plc.

Mallinckrodt Pharmaceuticals

F. Hoffmann-La Roche Ltd.

Endo Pharmaceuticals Inc.

Cardinal Health

Boehringer Ingelheim International GmbH

Bausch Health Companies Inc.

Amneal Pharmaceuticals

Abbott Laboratories, Inc.

Human Pain Management Drug Segment by Type

OTC

Rx

Human Pain Management Drug Segment by Application

Hospital

Retail Pharmacy

Other

Human Pain Management Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Pain Management Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Pain Management Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Pain Management Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Human Pain Management Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Human Pain Management Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Human Pain Management Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Human Pain Management Drug Market Share by Region (2021-2026) Table 4. Global Human Pain Management Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Human Pain Management Drug Market Share by Region (2027-2032) Table 6. Global Human Pain Management Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Pain Management Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Human Pain Management Drug Market Size Share by Type (2021-2026) Table 9. Global Human Pain Management Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Human Pain Management Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Human Pain Management Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Human Pain Management Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Human Pain Management Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Human Pain Management Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Human Pain Management Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Human Pain Management Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Human Pain Management Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Human Pain Management Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Human Pain Management Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Human Pain Management Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Human Pain Management Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Human Pain Management Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Human Pain Management Drug Market Size Share by Application (2021-2026) Table 24. Global Human Pain Management Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Human Pain Management Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Human Pain Management Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Human Pain Management Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Human Pain Management Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Human Pain Management Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Human Pain Management Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Human Pain Management Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Human Pain Management Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Human Pain Management Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Human Pain Management Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Human Pain Management Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Human Pain Management Drug Industry Trends Table 37. Human Pain Management Drug Industry Drivers Table 38. Human Pain Management Drug Industry Opportunities and Challenges Table 39. Human Pain Management Drug Industry Restraints Table 40. Global Human Pain Management Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Human Pain Management Drug Revenue Market Share by Company (2021-2026) Table 42. Global Human Pain Management Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Human Pain Management Drug Key Company Headquarters & Area Served Table 44. Global Human Pain Management Drug Company, Product Type & Application Table 45. Global Human Pain Management Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Human Pain Management Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Pharmaceuticals Ltd. Company Information Table 49. Teva Pharmaceuticals Ltd. Business Overview Table 50. Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Pharmaceuticals Ltd. Human Pain Management Drug Product Portfolio Table 52. Teva Pharmaceuticals Ltd. Recent Development Table 53. Sun Pharmaceutical Industries Ltd. Company Information Table 54. Sun Pharmaceutical Industries Ltd. Business Overview Table 55. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product Portfolio Table 57. Sun Pharmaceutical Industries Ltd. Recent Development Table 58. Sanofi S.A. Company Information Table 59. Sanofi S.A. Business Overview Table 60. Sanofi S.A. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi S.A. Human Pain Management Drug Product Portfolio Table 62. Sanofi S.A. Recent Development Table 63. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information Table 64. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview Table 65. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product Portfolio Table 67. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis AG Human Pain Management Drug Product Portfolio Table 72. Novartis AG Recent Development Table 73. Pfizer Inc. Company Information Table 74. Pfizer Inc. Business Overview Table 75. Pfizer Inc. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Inc. Human Pain Management Drug Product Portfolio Table 77. Pfizer Inc. Recent Development Table 78. GSK plc. Company Information Table 79. GSK plc. Business Overview Table 80. GSK plc. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GSK plc. Human Pain Management Drug Product Portfolio Table 82. GSK plc. Recent Development Table 83. Bayer AG Company Information Table 84. Bayer AG Business Overview Table 85. Bayer AG Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bayer AG Human Pain Management Drug Product Portfolio Table 87. Bayer AG Recent Development Table 88. Bristol Myers Squibb Co. Company Information Table 89. Bristol Myers Squibb Co. Business Overview Table 90. Bristol Myers Squibb Co. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bristol Myers Squibb Co. Human Pain Management Drug Product Portfolio Table 92. Bristol Myers Squibb Co. Recent Development Table 93. AbbVie Inc. (Allergan plc) Company Information Table 94. AbbVie Inc. (Allergan plc) Business Overview Table 95. AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AbbVie Inc. (Allergan plc) Human Pain Management Drug Product Portfolio Table 97. AbbVie Inc. (Allergan plc) Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AstraZeneca Human Pain Management Drug Product Portfolio Table 102. AstraZeneca Recent Development Table 103. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information Table 104. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview Table 105. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product Portfolio Table 107. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development Table 108. Viatris Company Information Table 109. Viatris Business Overview Table 110. Viatris Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Viatris Human Pain Management Drug Product Portfolio Table 112. Viatris Recent Development Table 113. Purdue Pharmaceuticals L.P. Company Information Table 114. Purdue Pharmaceuticals L.P. Business Overview Table 115. Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Purdue Pharmaceuticals L.P. Human Pain Management Drug Product Portfolio Table 117. Purdue Pharmaceuticals L.P. Recent Development Table 118. Procter & Gamble Company Information Table 119. Procter & Gamble Business Overview Table 120. Procter & Gamble Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Procter & Gamble Human Pain Management Drug Product Portfolio Table 122. Procter & Gamble Recent Development Table 123. Perrigo Company Plc. Company Information Table 124. Perrigo Company Plc. Business Overview Table 125. Perrigo Company Plc. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Perrigo Company Plc. Human Pain Management Drug Product Portfolio Table 127. Perrigo Company Plc. Recent Development Table 128. Mallinckrodt Pharmaceuticals Company Information Table 129. Mallinckrodt Pharmaceuticals Business Overview Table 130. Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Mallinckrodt Pharmaceuticals Human Pain Management Drug Product Portfolio Table 132. Mallinckrodt Pharmaceuticals Recent Development Table 133. F. Hoffmann-La Roche Ltd. Company Information Table 134. F. Hoffmann-La Roche Ltd. Business Overview Table 135. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product Portfolio Table 137. F. Hoffmann-La Roche Ltd. Recent Development Table 138. Endo Pharmaceuticals Inc. Company Information Table 139. Endo Pharmaceuticals Inc. Business Overview Table 140. Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Endo Pharmaceuticals Inc. Human Pain Management Drug Product Portfolio Table 142. Endo Pharmaceuticals Inc. Recent Development Table 143. Cardinal Health Company Information Table 144. Cardinal Health Business Overview Table 145. Cardinal Health Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Cardinal Health Human Pain Management Drug Product Portfolio Table 147. Cardinal Health Recent Development Table 148. Boehringer Ingelheim International GmbH Company Information Table 149. Boehringer Ingelheim International GmbH Business Overview Table 150. Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Boehringer Ingelheim International GmbH Human Pain Management Drug Product Portfolio Table 152. Boehringer Ingelheim International GmbH Recent Development Table 153. Bausch Health Companies Inc. Company Information Table 154. Bausch Health Companies Inc. Business Overview Table 155. Bausch Health Companies Inc. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Bausch Health Companies Inc. Human Pain Management Drug Product Portfolio Table 157. Bausch Health Companies Inc. Recent Development Table 158. Amneal Pharmaceuticals Company Information Table 159. Amneal Pharmaceuticals Business Overview Table 160. Amneal Pharmaceuticals Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Amneal Pharmaceuticals Human Pain Management Drug Product Portfolio Table 162. Amneal Pharmaceuticals Recent Development Table 163. Abbott Laboratories, Inc. Company Information Table 164. Abbott Laboratories, Inc. Business Overview Table 165. Abbott Laboratories, Inc. Human Pain Management Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Abbott Laboratories, Inc. Human Pain Management Drug Product Portfolio Table 167. Abbott Laboratories, Inc. Recent Development Table 168. North America Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Human Pain Management Drug Market Share by Country (2021-2026) Table 171. North America Human Pain Management Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Human Pain Management Drug Market Share Forecast by Country (2027-2032) Table 173. Europe Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Human Pain Management Drug Market Share by Country (2021-2026) Table 176. Europe Human Pain Management Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Human Pain Management Drug Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Human Pain Management Drug Market Share by Country (2021-2026) Table 181. Asia-Pacific Human Pain Management Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Human Pain Management Drug Market Share Forecast by Country (2027-2032) Table 183. Latin America Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Human Pain Management Drug Market Share by Country (2021-2026) Table 186. Latin America Human Pain Management Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Human Pain Management Drug Market Share Forecast by Country (2027-2032) Table 188. Middle East & Africa Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East & Africa Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East & Africa Human Pain Management Drug Market Share by Country (2021-2026) Table 191. Middle East & Africa Human Pain Management Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East & Africa Human Pain Management Drug Market Share Forecast by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Human Pain Management Drug Product Image Figure 3. Global Human Pain Management Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Human Pain Management Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Human Pain Management Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Human Pain Management Drug Market Share by Region (2021-2032) Figure 7. North America Human Pain Management Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Human Pain Management Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Human Pain Management Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Human Pain Management Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Human Pain Management Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. OTC Image Figure 13. Global OTC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Rx Image Figure 15. Global Rx Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Human Pain Management Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Human Pain Management Drug Market Share by Type 2025 VS 2032 Figure 18. North America Human Pain Management Drug Market Size Share by Type (2021-2032) Figure 19. Europe Human Pain Management Drug Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Human Pain Management Drug Market Size Share by Type (2021-2032) Figure 21. Latin America Human Pain Management Drug Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Human Pain Management Drug Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Human Pain Management Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Human Pain Management Drug Market Share by Application 2025 VS 2032 Figure 31. North America Human Pain Management Drug Market Size Share by Application (2021-2032) Figure 32. Europe Human Pain Management Drug Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Human Pain Management Drug Market Size Share by Application (2021-2032) Figure 34. Latin America Human Pain Management Drug Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Human Pain Management Drug Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Human Pain Management Drug Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Human Pain Management Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Human Pain Management Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Human Pain Management Drug Market Share by Country (2021-2032) Figure 41. Europe Human Pain Management Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Human Pain Management Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Human Pain Management Drug Market Share by Country (2021-2032) Figure 44. Asia-Pacific Human Pain Management Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Human Pain Management Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Human Pain Management Drug Market Share by Country (2021-2032) Figure 47. Latin America Human Pain Management Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Human Pain Management Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Human Pain Management Drug Market Share by Country (2021-2032) Figure 50. Middle East & Africa Human Pain Management Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Human Pain Management Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Human Pain Management Drug Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Rx
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Teva Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  • Novartis AG
  • Pfizer Inc.
  • GSK plc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • AbbVie Inc. (Allergan plc)
  • AstraZeneca
  • Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  • Viatris
  • Purdue Pharmaceuticals L.P.
  • Procter & Gamble
  • Perrigo Company Plc.
  • Mallinckrodt Pharmaceuticals
  • F. Hoffmann-La Roche Ltd.
  • Endo Pharmaceuticals Inc.
  • Cardinal Health
  • Boehringer Ingelheim International GmbH
  • Bausch Health Companies Inc.
  • Amneal Pharmaceuticals
  • Abbott Laboratories, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Human Pain Management Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Human Pain Management Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Human Pain Management Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Human Pain Management Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Human Pain Management Drug Market Size (2021-2032)
  8. 1.5.1 North America Human Pain Management Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Human Pain Management Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Human Pain Management Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Human Pain Management Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Human Pain Management Drug Market Size Growth Rate (2021-2032)
2 Human Pain Management Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 OTC
  3. 2.1.2 Rx
  4. 2.2 Global Human Pain Management Drug Market Size by Type
  5. 2.2.1 Global Human Pain Management Drug Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Human Pain Management Drug Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Human Pain Management Drug Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Human Pain Management Drug Market Size by Regions
  9. 2.3.1 North America Human Pain Management Drug Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Human Pain Management Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Human Pain Management Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Human Pain Management Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Human Pain Management Drug Market Size Breakdown by Type (2021-2026)
3 Human Pain Management Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Human Pain Management Drug Market Size by Application
  6. 3.2.1 Global Human Pain Management Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Human Pain Management Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Human Pain Management Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Human Pain Management Drug Market Size by Regions
  10. 3.3.1 North America Human Pain Management Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Human Pain Management Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Human Pain Management Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Human Pain Management Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Human Pain Management Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Human Pain Management Drug Industry Trends
  2. 4.2 Human Pain Management Drug Industry Drivers
  3. 4.3 Human Pain Management Drug Industry Opportunities and Challenges
  4. 4.4 Human Pain Management Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Human Pain Management Drug Revenue (2021-2026)
  2. 5.2 Global Human Pain Management Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Human Pain Management Drug Key Company Headquarters & Area Served
  4. 5.4 Global Human Pain Management Drug Company, Product Type & Application
  5. 5.5 Global Human Pain Management Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Human Pain Management Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Human Pain Management Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Human Pain Management Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals Ltd.
  2. 6.1.1 Teva Pharmaceuticals Ltd. Company Information
  3. 6.1.2 Teva Pharmaceuticals Ltd. Business Overview
  4. 6.1.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Ltd. Human Pain Management Drug Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Ltd. Recent Developments
  7. 6.2 Sun Pharmaceutical Industries Ltd.
  8. 6.2.1 Sun Pharmaceutical Industries Ltd. Company Information
  9. 6.2.2 Sun Pharmaceutical Industries Ltd. Business Overview
  10. 6.2.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  13. 6.3 Sanofi S.A.
  14. 6.3.1 Sanofi S.A. Company Information
  15. 6.3.2 Sanofi S.A. Business Overview
  16. 6.3.3 Sanofi S.A. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi S.A. Human Pain Management Drug Product Portfolio
  18. 6.3.5 Sanofi S.A. Recent Developments
  19. 6.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  20. 6.4.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information
  21. 6.4.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
  22. 6.4.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product Portfolio
  24. 6.4.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
  25. 6.5 Novartis AG
  26. 6.5.1 Novartis AG Company Information
  27. 6.5.2 Novartis AG Business Overview
  28. 6.5.3 Novartis AG Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis AG Human Pain Management Drug Product Portfolio
  30. 6.5.5 Novartis AG Recent Developments
  31. 6.6 Pfizer Inc.
  32. 6.6.1 Pfizer Inc. Company Information
  33. 6.6.2 Pfizer Inc. Business Overview
  34. 6.6.3 Pfizer Inc. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Inc. Human Pain Management Drug Product Portfolio
  36. 6.6.5 Pfizer Inc. Recent Developments
  37. 6.7 GSK plc.
  38. 6.7.1 GSK plc. Company Information
  39. 6.7.2 GSK plc. Business Overview
  40. 6.7.3 GSK plc. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GSK plc. Human Pain Management Drug Product Portfolio
  42. 6.7.5 GSK plc. Recent Developments
  43. 6.8 Bayer AG
  44. 6.8.1 Bayer AG Company Information
  45. 6.8.2 Bayer AG Business Overview
  46. 6.8.3 Bayer AG Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bayer AG Human Pain Management Drug Product Portfolio
  48. 6.8.5 Bayer AG Recent Developments
  49. 6.9 Bristol Myers Squibb Co.
  50. 6.9.1 Bristol Myers Squibb Co. Company Information
  51. 6.9.2 Bristol Myers Squibb Co. Business Overview
  52. 6.9.3 Bristol Myers Squibb Co. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bristol Myers Squibb Co. Human Pain Management Drug Product Portfolio
  54. 6.9.5 Bristol Myers Squibb Co. Recent Developments
  55. 6.10 AbbVie Inc. (Allergan plc)
  56. 6.10.1 AbbVie Inc. (Allergan plc) Company Information
  57. 6.10.2 AbbVie Inc. (Allergan plc) Business Overview
  58. 6.10.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Inc. (Allergan plc) Human Pain Management Drug Product Portfolio
  60. 6.10.5 AbbVie Inc. (Allergan plc) Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Human Pain Management Drug Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  68. 6.12.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information
  69. 6.12.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
  70. 6.12.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product Portfolio
  72. 6.12.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments
  73. 6.13 Viatris
  74. 6.13.1 Viatris Company Information
  75. 6.13.2 Viatris Business Overview
  76. 6.13.3 Viatris Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Viatris Human Pain Management Drug Product Portfolio
  78. 6.13.5 Viatris Recent Developments
  79. 6.14 Purdue Pharmaceuticals L.P.
  80. 6.14.1 Purdue Pharmaceuticals L.P. Company Information
  81. 6.14.2 Purdue Pharmaceuticals L.P. Business Overview
  82. 6.14.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Purdue Pharmaceuticals L.P. Human Pain Management Drug Product Portfolio
  84. 6.14.5 Purdue Pharmaceuticals L.P. Recent Developments
  85. 6.15 Procter & Gamble
  86. 6.15.1 Procter & Gamble Company Information
  87. 6.15.2 Procter & Gamble Business Overview
  88. 6.15.3 Procter & Gamble Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Procter & Gamble Human Pain Management Drug Product Portfolio
  90. 6.15.5 Procter & Gamble Recent Developments
  91. 6.16 Perrigo Company Plc.
  92. 6.16.1 Perrigo Company Plc. Company Information
  93. 6.16.2 Perrigo Company Plc. Business Overview
  94. 6.16.3 Perrigo Company Plc. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Perrigo Company Plc. Human Pain Management Drug Product Portfolio
  96. 6.16.5 Perrigo Company Plc. Recent Developments
  97. 6.17 Mallinckrodt Pharmaceuticals
  98. 6.17.1 Mallinckrodt Pharmaceuticals Company Information
  99. 6.17.2 Mallinckrodt Pharmaceuticals Business Overview
  100. 6.17.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Mallinckrodt Pharmaceuticals Human Pain Management Drug Product Portfolio
  102. 6.17.5 Mallinckrodt Pharmaceuticals Recent Developments
  103. 6.18 F. Hoffmann-La Roche Ltd.
  104. 6.18.1 F. Hoffmann-La Roche Ltd. Company Information
  105. 6.18.2 F. Hoffmann-La Roche Ltd. Business Overview
  106. 6.18.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product Portfolio
  108. 6.18.5 F. Hoffmann-La Roche Ltd. Recent Developments
  109. 6.19 Endo Pharmaceuticals Inc.
  110. 6.19.1 Endo Pharmaceuticals Inc. Company Information
  111. 6.19.2 Endo Pharmaceuticals Inc. Business Overview
  112. 6.19.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Endo Pharmaceuticals Inc. Human Pain Management Drug Product Portfolio
  114. 6.19.5 Endo Pharmaceuticals Inc. Recent Developments
  115. 6.20 Cardinal Health
  116. 6.20.1 Cardinal Health Company Information
  117. 6.20.2 Cardinal Health Business Overview
  118. 6.20.3 Cardinal Health Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Cardinal Health Human Pain Management Drug Product Portfolio
  120. 6.20.5 Cardinal Health Recent Developments
  121. 6.21 Boehringer Ingelheim International GmbH
  122. 6.21.1 Boehringer Ingelheim International GmbH Company Information
  123. 6.21.2 Boehringer Ingelheim International GmbH Business Overview
  124. 6.21.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Boehringer Ingelheim International GmbH Human Pain Management Drug Product Portfolio
  126. 6.21.5 Boehringer Ingelheim International GmbH Recent Developments
  127. 6.22 Bausch Health Companies Inc.
  128. 6.22.1 Bausch Health Companies Inc. Company Information
  129. 6.22.2 Bausch Health Companies Inc. Business Overview
  130. 6.22.3 Bausch Health Companies Inc. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Bausch Health Companies Inc. Human Pain Management Drug Product Portfolio
  132. 6.22.5 Bausch Health Companies Inc. Recent Developments
  133. 6.23 Amneal Pharmaceuticals
  134. 6.23.1 Amneal Pharmaceuticals Company Information
  135. 6.23.2 Amneal Pharmaceuticals Business Overview
  136. 6.23.3 Amneal Pharmaceuticals Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Amneal Pharmaceuticals Human Pain Management Drug Product Portfolio
  138. 6.23.5 Amneal Pharmaceuticals Recent Developments
  139. 6.24 Abbott Laboratories, Inc.
  140. 6.24.1 Abbott Laboratories, Inc. Company Information
  141. 6.24.2 Abbott Laboratories, Inc. Business Overview
  142. 6.24.3 Abbott Laboratories, Inc. Human Pain Management Drug Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Abbott Laboratories, Inc. Human Pain Management Drug Product Portfolio
  144. 6.24.5 Abbott Laboratories, Inc. Recent Developments
7 North America
  1. 7.1 North America Human Pain Management Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Human Pain Management Drug Market Size by Country (2021-2026)
  3. 7.3 North America Human Pain Management Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Human Pain Management Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Human Pain Management Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Human Pain Management Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Human Pain Management Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Human Pain Management Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Human Pain Management Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Human Pain Management Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Human Pain Management Drug Market Size by Country (2021-2026)
  3. 10.3 South America Human Pain Management Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Human Pain Management Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Human Pain Management Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Human Pain Management Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst